Detalhe da pesquisa
1.
Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in Participants With or at High Risk for Atherosclerotic Cardiovascular Disease: Rationale and Designs of BROADWAY and BROOKLYN.
Am Heart J
; 2024 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38705341
2.
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
Curr Atheroscler Rep
; 26(2): 35-44, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38133847
3.
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief Report.
Arterioscler Thromb Vasc Biol
; 42(12): 1461-1467, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36325899
4.
Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis.
BMC Nephrol
; 23(1): 34, 2022 01 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35034619
5.
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
J Am Soc Nephrol
; 32(1): 211-222, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33272965
6.
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels.
Int J Mol Sci
; 23(16)2022 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36012684
7.
The clinical black, white, and gray lessons.
Curr Opin Lipidol
; 32(2): 151-156, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33651748
8.
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Endocr Pract
; 26(10): 1196-1224, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33471721
9.
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
JAMA
; 324(22): 2268-2280, 2020 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33190147
10.
Can We Cure Atherosclerosis?
Rev Cardiovasc Med
; 19(S1): S20-S24, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30207554
11.
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
Rev Cardiovasc Med
; 19(S1): S31-S46, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30207556
12.
How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.
Curr Cardiol Rep
; 20(12): 138, 2018 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-30328514
13.
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.
Circulation
; 134(24): 1931-1943, 2016 Dec 13.
Artigo
Inglês
| MEDLINE | ID: mdl-27777279
14.
The future of n-3 polyunsaturated fatty acid therapy.
Curr Opin Lipidol
; 27(6): 570-578, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27798489
15.
Reducing residual cardiovascular risk with novel therapies.
Curr Opin Lipidol
; 31(2): 108-110, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32132416
16.
Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
Arterioscler Thromb Vasc Biol
; 34(6): 1298-306, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24743431
17.
Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy.
Cardiovasc Drugs Ther
; 29(1): 41-50, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25702642
18.
Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
Lipids Health Dis
; 14: 98, 2015 Sep 02.
Artigo
Inglês
| MEDLINE | ID: mdl-26328624
19.
Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population.
Echocardiography
; 32(2): 264-70, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24930883
20.
Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice.
Rev Cardiovasc Med
; 15(1): 1-10, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24762461